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The use of complementary and alternative medicine (CAM) is
increasing rapidly. The World Health Organization (WHO)
classifies 65–80% of the world’s health care services as ‘tradi-
tional medicine’ (1). Therefore, from the viewpoint of the
population ratio, more people use CAM than modern western
medicine.
Although much attention has been focused on CAM not only
from physicians but also basic medical researchers, scientific
evidence for most CAM is still sparse. Emergence of CAM as
a new current of medicine depends on whether or not precise
scientific evidence can be accumulated.
Why has CAM become so popular among ‘consumers’?
I think that the following factors are responsible:
● CAM is easy to understand and familiar
● CAM is non-invasive, with few side effects
● CAM helps improve quality of life (QOL) or activity of
daily life (ADL)
● CAM helps one to maintain one’s own health
● Western modern medicine does not fully correspond to
the patients’ demands
● the trend towards a more holistic medical approach
● ballooning medical expenses
In this overview, I will describe and discuss the current
status of CAM in Japan.
The situation in Japan should be of much interest, since
Japan is unique as a country in which highly advanced modern
Western medicine coexists with traditional Asian medicine.
Classification of CAM
CAM, as defined by The National Center for Complementary
and Alternative Medicine (NCCAM) in the USA, is a group of
diverse medical and health care systems, practices and prod-
ucts that are not presently considered to be part of conven-
tional Western medicine. NCCAM classifies CAM therapies
into five categories, or domains (Table 1).
In Japan, part of anti-aging medicine (growth hormone treat-
ment, etc), lifestyle drugs (remedies for alopecia, obesity,
impotence, etc) and ‘environmental medicine’ are considered
to be included in CAM treatment. For example, developing a
functional food which absorbs dioxins and promotes discharge
into facilities, or developing a filter to trap the free radicals of
automobile exhaust gas or cigarette smoke, etc, are included in
the category of ‘environmental medicine’.
The CAM domain in Japan also encompasses some forms of
advanced medical treatments, which are not yet widely carried
out, such as immunotherapy for cancer using tumor specific
antigens, etc. In-vitro fertilization and embryo transfer
(IVF/ET), one of the most advanced medical technologies, was
regarded as CAM at the very beginning. Now, however,
IVF/ET is widely used in conventional hospitals, so it can be
said that some CAM modalities have been taken into conven-
tional medical treatment. So, in Japan CAM has some conno-
tations of ‘frontier’ medicine.
Unlike Western countries, in Japan, part of Kampo medicine
(Japanese herbal medicine) and acupuncture are covered by
public health insurance. Therefore, Japanese practitioners of
Kampo and acupuncture would object to their inclusion in
CAM and would rather regard themselves as belonging to the
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Table 1. Classification of CAM therapies
1. Alternative medical systems Traditional Chinese medicine,
Ayurveda, homeopathic medicine,
chiropractic, naturopathic 
medicine, etc.
2. Mind–body interventions Meditation, prayer, mental healing,
art, dance, music therapy, etc.
3. Biologically based therapies Foods, herbs, vitamins, dietary
supplements, aromatherapy, etc.
4. Manipulative and body-based  Chiropractic or osteopathic 
methods manipulation, and massage, etc.
5. Energy therapies 
Biofield therapies Qi gong, therapeutic touch
Bioelectromagnetic-based Electromagnetic  fields
therapies
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derivative work this must be clearly indicated.authentic traditional medicine. However, these treatments are
categorized as CAM in Europe and the USA. Thus, the defini-
tion of CAM differs slightly from country to country.
Japanese doctors’ attitudes to CAM are unique, as found in
the study carried out Imanishi et al. (2). Some form of comple-
mentary medicine was practiced by 267 of their respondents
(73%), the most common being Kampo (70% of the respond-
ents). Surprisingly, almost all doctors practicing complemen-
tary medicine were Kampo practitioners (96%). A few doctors
(8%) practiced other forms of alternative medicine including
chiropractic, aromatherapy, homeopathy, health spa therapy,
Ayurveda, hypnosis, flower therapy, thalassotherapy, herb
therapy, qigong, yoga, dietary therapy, imagery, meditation, art
therapy and prayer. This result is very different from that of
doctors in European and North American countries (3). Thus,
Kampo is by far the most frequently practiced CAM modality
by doctors themselves. I think this situation, namely adoption
of Kampo by many doctors educated in Western medicine, is
the most characteristic feature of CAM in Japan.
Acupuncture, electroacupuncture and moxibustion are prac-
ticed by acupuncturists and specialists in moxibustion rather
than by doctors, because they need special training, unlike pre-
scribing Kampo medicine. In Japan, after 3 years of education
at a professional school of acupuncture, moxibustion, acupres-
sure or massage, one can obtain a license to practice after pass-
ing the national examination. However, medical doctors are
permitted to perform any one of the above treatments even if
they do not attend one of these schools. However, not many
medical doctors would actually be trained in the practice of
these modalities. They are usually left to specialists.
Judo has been very popular since ancient times. Because
injuries such as fracture or dislocation were frequent among judo
wrestlers, unique orthopedic techniques have been developed by
Judo practitioners over hundreds of years. The government thus
recognizes Judo-Orthopedics as a distinct paramedical profes-
sion. To obtain a national license for Judo-Orthopedics, one must
be educated for 3 years under licensed Judo orthodedicians. In
contrast, chiropractic and osteopathy, which are widely used in
the USA, are not authorized by the Japanese government.
Patients using CAM are not exclusively human. Recently, the
popularity of pet ownership has risen in Japan. Since a pet is
usually considered to be a member of the family, the owner is
concerned that the pet receives good medical care, including
CAM modalities. In response to owners’ strong desires, CAM
treatment by veterinarians is on the increase, including acupunc-
ture, aromatherapy and herbal therapy. Of particular note is the
widespread use of dietary supplements, thus many companies
are researching and developing these specifically for animals.
Validation of Traditional CAM Modalities:
A Proposal
In general, I believe CAM domains should be studied using the
scientific research methods of modern Western medicine.
However, for those traditional modalities which have already
become part of the lifestyle in one country (or culture), their
verification procedure would somewhat differ from that of
Western modern medicine.
Figure 1 illustrates a proposed flowchart of the research
method on CAM modalities, which have been traditionally
employed without modern scientific endorsement. The first step
should be focused on clinical trial to confirm efficacy and use-
fulness. Of course, before performing a clinical trial, it is neces-
sary to complete safety testing in the modern scientific format,
such as toxicity tests on animals. If the results of a clinical trial
are desirable, basic research to identify and elucidate the action
mechanism of the modality will be needed. Nowadays, users
receive most CAM modalities at their own expense, but part of
it may be able to gain government approval. I would like to
point out that this is just the reverse order of when a new agent
is introduced in modern Western medicine.
In Japan, more physicians are now attracted to CAM
research, because they envisage that they will learn new
medical methods, which have high practicality as well as high
cost performance and safety. Furthermore, from the viewpoint
of basic medicine, CAM offers unexpected opportunities to
discover new substances and new mechanisms.
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Figure 1. Flowchart of scientific research method.History of CAM: Japan and the USA
Compared
First of all, I wish to share the reason why I entered into this
field. In 1990 I was working as a physician of obstetrics and
gynecology at Keiju General Hospital in northern Japan. One
day, I came across a curious case. I had planned to operate on
an 18-year-old female patient who suffered from condyloma
acuminatum. Condyloma acuminatum is a troublesome dis-
ease for ob/gyn physicians. It is hard to cure completely, and
even after surgery patients still feel much pain. I was therefore
not anticipating the operation with much enthusiasm. On the
day of the operation, however, I was astonished to see that the
lesions had completely disappeared. There should have been
many condyloma lesions that had spread from the outer gen-
italia to the vaginal wall! Soon the reason for her spontaneous
recovery became clear. Her grandmother had given her a
kind of food that consisted of various natural products which
mainly contained fermented coix seeds (a kind of wheat). She
got the seeds from her grandmother, and was sure that it had
worked wonders on the condyloma. This was my first contact
with traditional folk medicine so effective as to outperform all
of the Western medical modalities, including surgery, in which
I had been trained. I have been interested in CAM from that
time and now I am investigating the fundamental aspects and
clinical efficacy of this food with my colleagues.
Table 2 shows the history of CAM in Japan and the USA. In
1990, soon after the above event, a small research group of physi-
cians for CAM was born at Kanazawa University. In 1997, this
group established the Japanese Society for Complementary and
Alternative Medicine (JCAM). The members of JCAM are doc-
tors, nurses, dentists, veterinarians, acupuncturists, nutritionists,
pharmacists and researchers of various basic sciences. After the
foundation of JCAM, another society, the Japanese Association
for Alternative, Complementary and Traditional Medicine
(JACT) and the Japanese Society for Integrative Medicine (JIM)
were successively initiated. JACT is more interested in promot-
ing collaboration among existing societies related to CAM and
traditional medicine than exploring the CAM field per se.
The medical societies in Japan relevant to CAM domains are
shown in Table 3. Most of these societies do not yet have a
common commitment on CAM.
In 1999, the International Research Center for Traditional
Medicine was founded in Toyama prefecture. Research into
Ayurveda (hot spring therapy) is being conducted (Fig. 2).
In 2002, the CAM department was founded at Kanazawa
National University. I hope to introduce the activity of this
department and education of CAM in a forthcoming Review art-
icle in this journal, which will focus on CAM research in Japan.
In the USA, to address the increasing need for research in
CAM, Congress created the Office of Alternative Medicine
(OAM) in 1992 at the National Institutes of Health (NIH).
Funds allocated for the OAM were 2 million US dollars in
1992 and 1993, and steadily grew to 12 million US dollars in
1997 (1). In 1998, OAM came to be known as the National
Center for Complementary and Alternative Medicine
(NCCAM) (4). Now, the funds for NCCAM are over 100 
million US dollars. NCCAM spends funds on CAM-related
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Table 2. History of CAM (Japan and USA)
Year Group/Association formed Location
1990 A small research group for CAM at Kanazawa University Japan
1992 Office of Alternative Medicine (OAM) in NIH USA
1997 Japanese Society for Complementary and Alternative Medicine (JCAM) Japan
1998 National Center for Complementary and Alternative Medicine (NCCAM) USA
Japanese Association for Alternative, Complementary and Traditional Medicine (JACT) Japan
1999 International Research Center for Traditional Medicine Japan
2001 Japanese Society for Integrative Medicine (JIM) Japan
2002 Department for Complementary and Alternative Medicine, Kanazawa University Graduate Japan
School of Medical Science
Table 3. Japanese societies in the domain of CAM
Japanese Society for Complementary and Alternative Medicine (JCAM)
Japanese Association for Alternative, Complementary and Traditional
Medicine (JACT)
Japanese Society for Integrative Medicine (JIM)
Japanese Society of Aromatherapy
Japan Society of Acupuncture and Moxibustion
Japan Traditional Acupuncture and Moxibustion Society
Japan Dental Society of Oriental Medicine
Japan Society for Oriental Medicine
Medical and Pharmaceutical Society for WAKAN-YAKU
Japan Pre-symptomatic Medical System Society
Japanese Association of Physical medicine, Balneology and Climatology
Japanese Society of Psychopathology of Expression and Arts Therapy
Japanese Society of Biofeedback Research
Society of Hemorheology and Related Research
Japan Medical Conference on Magnetism
Japan Music Therapy Association
Japan Biomusic Association
Japan Fasting Therapy Society
othersresearch, and the major part of this research goes toward areas
already largely accepted by conventional scientists, such as
antioxidants or dietary manipulation.
CAM in the Japanese Modern Western
Medical Society
Table 4 shows CAM symposia or lectures held by Japanese
modern Western medical societies from 2002 to 2004, showing
a significant change in the acceptance of CAM by these
societies.
In 1999, ASCO (American Society of Clinical Oncology)
held their 35th Annual Meeting. This congress included the
symposium ‘Alternative and Complementary Therapies and
Oncologic Care’. Three years later, JSCO (Japan Society of
Clinical Oncology) held their 40th Annual Meeting, including
the symposium ‘Alternative Medicine and Oncologic Care’.
Alternative medicine appeared in the Journal of the American
Medical Association (JAMA) as a ‘JAMA patient page.
Alternative choices: what it means to use unconventional medi-
cine’ (5). Five years later, a lecture about CAM was given at
The 26th General Assembly of the Japan Medical Congress.
This is the biggest medical congress held every 4 years by the
Japanese Medical Association. Thus, CAM is now rapidly
entering into mainstream medicine in Japan.
Attitude of the Japanese Government Toward
CAM Domains
In sharp contrast to the USA, the attitude of the Japanese gov-
ernment toward CAM was slow to change. This was partly
because the government has long recognized traditional medical
modalities, such as acupuncture and Kampo medicine as legiti-
mate medical practice. But at the same time this slowness also
shows that the government was not so interested in introducing
any critical standards into various CAM modalities. Recently,
however, an Advisory Panel of the Health, Labor and Welfare
Ministry was established to investigate CAM in cancer therapy.
Dr I. Hyodo of the National Shikoku Cancer Center is the chief
of this committee. He stated that ‘there is a lack of systematic
research concerning the evidence of CAM efficacy. Many
patients use CAM without enough accurate information. Many
oncologists tend to ignore CAM use. Such circumstances should
be improved as quickly as possible’. In 2002, Dr Hyodo and col-
leagues presented data of the cancer survey at the JSCO sympo-
sium mentioned above (Fig. 3). This initiative is symptomatic of
the Japanese situation of CAM, where the most crucial problem,
as perceived both by the government and the medical commu-
nity, is that of widespread use without sufficient scientific
evidence of various CAM modalities by cancer patients.
Furthermore, this committee reported on the perceptions and
attitudes of clinical oncologists towards CAM (6). The CAM
questionnaires were sent to 2118 clinical oncologists and
found that the majority of oncologists (82%) believed that
CAM products were ineffective against cancer. The main
reason for this belief was a lack of reliable information (as cited
by 85% of oncologists). Only 13% of oncologists had experi-
enced CAM-associated disease improvement in their cancer
patients. Negative perceptions of CAM products persist among
clinical oncologists. A lack of proven effectiveness of CAM
products and concerns about drug interactions with anticancer
treatment suggest a need for both accurate information on
CAM products and clinical trials. The same opinion is
expressed by others. For too long, the natural health products
industry has kept its distance from medical research and from
clinical medical practice, focusing instead on the short-term
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Table 4. CAM symposia or lectures in the field of modern Western medical
societies
Event Date
Japanese Society for Palliative Medicine June 2002
Japan Society of Clinical Oncology October 2002
General Assembly of the Japan Medical Congress April 2003
Japan Pediatric Society April 2003
Japan Society for Occupational Health April 2003
Japanese College of Surgeons June 2003
Japan Society of Obstetrics and Gynecology October 2003
Japanese Dermatological Association November 2003
Japan Epidemiological Association January 2004
Japanese Breast Cancer Society June 2004
Ayurveda
Figure 2. International Research Center for Traditional Medicine.marketing advantages derived from keeping herbal and nutri-
tional remedies exempt from Food and Drug Administration
(FDA) review of efficacy. A wiser approach would be for
the natural products industry to work with medical research,
including the FDA, so that consumers and medical practition-
ers could be warned about potential harm and assured that the
claimed health benefits were really there (7).
In 2003, the term ‘CAM’was adopted as a new key word of
‘the Grant-in-Aid for Scientific Research’ of the Ministry of
Education, Culture, Sports, Science and Technology. Because
Japan does not yet have an organization like NCCAM, the
CAM Department of Kanazawa University, which is a
National University, has to play a pivotal role equivalent to that
of NCCAM.
Different CAM Modalities Used in 
Japan and the USA
In the USA, CAM use increased from 33.8% in 1990 (8) to
42.1% in 1997 (9). CAM was used by 20–50% of the popula-
tion in many European countries (10,11) and 48.5% in
Australia (12). In Japan, 65.6% of adults used CAM (13)
(Table 5). A telephone survey of 1000 Japanese respondents
showed that the percentage of persons who had used at least
one CAM modality over the previous 12 months was greater
than the percentage of those who had used conventional
Western medicine (76.0 versus 65.6%) (14).
Furthermore, in the USA, 61.5% of the CAM users did not
tell their doctors, while 78.9% of the CAM users in Japan did
not tell theirs (9,13).
Table 6 shows the type of CAM used in the USA and Japan. In
Japan, the domain of dietary supplements is the most important,
followed by aromatherapy, traditional Chinese medicine
(Kampo), Ayurveda and electromagnetic fields. In addition to
these domains, hot spring bathing, lifestyle drugs, anti-aging
medicine and environmental medicine are thought to be impor-
tant. It should be noted that this is the order of CAM modalities
employed by users themselves. As I stated above, Kampo medi-
cine is by far the most frequently used modality in medical prac-
tice provided by licensed physicians.
A telephone survey revealed the percentage of use for each
CAM therapy as follows: nutritional and tonic drinks, 43.1%;
dietary supplements, 43.1%; health-related appliances, 21.5%;
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Figure 3. Cancer survey by Health, Labor and Welfare Ministry of Japan.
National Shikoku 
Cancer Center
Concerning CAM of cancer, an Advisory Panel of the Health, 
Labor and Welfare Ministry was established (2001)
Dr I Hyodo of the National Shikoku Cancer 
Center is the chief of this committee
Among the 750 cancer patients of hospitalization, 39.6% of 
them used some kind of CAM, and surprisingly, 89.1% of CAM 
users used dietary supplements. 
Cancer Survey
Table 5. Prevalence of CAM in USA and Japan
USA 42.1% of adults used CAM Eisenberg et al. (9)
Japan 65.6% of adults used CAM Kamohara (13)
Table 6. Type of CAM in Japan and USA
Japan Dietary supplements 42.0%
Massage 31.2%
Reflexology 20.2%
Aromatherapy 14.6%
Acupressure 13.2%
Herbs 12.3%
USA Relaxation 16.3%
Herbs 12.1%
Massage 11.1%
Chiropractic 11.0%
Mental healing 7.0%
Megavitamins 5.5%
Sources: Kamohara (13), Eisenberg et al. (9).herbs or over-the-counter Kampo, 17.2%; massage or acupres-
sure, 14.8%; ethical Kampo (Kampo prescribed by medical
doctors), 10.0%; aromatherapy, 9.3%; chiropractic or osteo-
pathy, 7.1%; acupuncture and moxibustion, 6.7%; homeopathy,
0.3%; other therapies, 6.5% (14). Regarding the reasons for the
use of CAM, 60.4% responded that ‘the condition was not seri-
ous enough to warrant conventional Western medicine’, and
49.3% were ‘expecting health enhancement or disease preven-
tion’. The average annual out-of-pocket expenditures of all
1000 respondents were half as much for CAM as for conven-
tional Western medicine (19 080 versus 38 360 yen).
According to these data, CAM is very popular in Japan and
the money spent is not negligible. It may strike the Western
reader that Japanese people are not so much interested in the
‘spiritual’modes of CAM, such as meditation and relaxation, as
in the ‘material’modes, such as dietary supplements, compared
with American people. I believe this reflects some deep differ-
ences in the two cultures.
Dietary Supplements in the USA and Japan
Popular dietary supplements in the USA include Gingko Biloba,
Echinacea, Garlic, Ginseng, Soybean, Saw Palmetto, St John’s
Wort, Valerian, Black Cohosh, Milk Thistle, Evening Primrose,
Grape Seed Extract, Bilberry, Green Tea, Pycnogenol, Ginger,
Feverfew and Dong quai, amongst others.
In Japan, an Agaricus blazei Murill is the most popular
product. Many cancer patients take this mushroom. Beer yeast,
Propolis, cereals, banaba, Japanese plum, Chlorella, barley
verdure, vegetable juice, collagen, royal jelly and mulberry are
also taken. These foods are quite different from the food sup-
plements popular in the USA. For example, Dong quai is a
food supplement in the USA but is classified as a medicine in
Japan. Dong quai is one ingredient used in Kampo.
Faced with the high tide of demands from consumers for
such various dietary supplements as above, the Japanese gov-
ernment introduced in 1993 a system of regulation on these
products. Producers of these supplements are required to sub-
mit data to prove their efficacy in order to sell them as health
dietary supplements, now called in translation ‘Special Health
Dietary Supplements (Tokuho)’. For example, a pharmaceut-
ical company put into the market a kind of green tea containing
high concentrations of catechin, for which they claim to have
evidence that it helps consumers reduce body fat. As of the end
of 2003, the market size was estimated to be around 5 billion
US dollars. Dietary supplements are certainly one of those rare
consumer goods, along with mobile phones and digital cam-
eras, sales of which have shown a phenomenal growth in the
otherwise sluggish Japanese economy of the last decade.
Clearly, scientific evaluation has become a mandatory require-
ment to guide consumers (or patients) in choosing only those
products that are truly beneficial for them.
Conclusion
I aimed in this Editorial to report the actual status of CAM in
Japan. CAM usage has become increasingly common among
Japanese citizens. Even though physicians are frequently
requested by their patients to advise them about CAM, there is
an absence of evidence for either efficacy or side effects for
almost all specific treatments. Nor are there any reliable guide-
lines that could help integration of CAM modalities with
conventional therapeutic modalities. Even so, courageous
scientists and clinicians are taking this up as a challenge.
Just as outer space has been an unknown frontier for human
beings from ancient times, the span of the domain of CAM is
also beyond all expectations. CAM is filled with new and
amazing discoveries, and it will increase people’s welfare.
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